Gastroenterologists predict CMS 'Death Blow' to
Ambulatory Surgery Centers
BETHESDA, Md., July 17 /PRNewswire-USNewswire/
-- Last night, the
Centers for Medicare and Medicaid Services (CMS)
announced a final rule on payment policies for
Ambulatory Surgical Centers (ASCs) which cuts
facility fees dramatically starting in January
2008. When fully implemented in 2011, CMS
expects to pay ASCs at approximately 65% of the
outpatient hospital rate, whereas GI ASCs are
generally paid now at approximately 89% of the
outpatient hospital rate.
These unfair and arbitrary cuts to reimbursement
for endoscopic
procedures performed in the ambulatory setting
create false economic
incentives that will have a devastating impact
on access to care by
Medicare beneficiaries which could severely
limit use of lifesaving
colorectal cancer screening tests.
ASCs provide a safe, convenient and
cost-effective environment for GI
endoscopic services, which include screening
tests for gastrointestinal
cancers and other chronic digestive disorders.
CMS's new rule creates
profound and disproportionate negative impact on
GI ASCs. Services provided in ASCs ultimately
will be reimbursed at a rate that is actually
below costs, according to an analysis performed
by the Lewin Group and placed in the record of
this rulemaking.
"The American College of Gastroenterology
predicts that CMS has dealt a disastrous
death blow to GI ASCs through draconian cuts
to payment. This ill- conceived and unfair
scheme threatens public health by severely
limiting access to colorectal cancer
screening in what is widely accepted as a
safe, cost-effective setting for delivery of
these health care services," explained ACG
President David A. Johnson, M.D., FACG.
"Further, the rule will force Medicare patients
to migrate back into the more expensive hospital
outpatient setting, ultimately costing the
federal government more."
According to the ACG, there are already
significant barriers to
screening for colon cancer, the second leading
cancer killer among men and women, and dramatic
under-utilization by Medicare patients of this
lifesaving method of early detection. The
College fears that use of the Medicare
colorectal screening benefit, under this new
federal rule, will decline further still.
"In life and death terms, many Medicare
beneficiaries will die unnecessarily if the
access to sites where colonoscopies can be
performed is reduced by the closing of GI ASCs.
Waiting times for screening will increase, and
the overall rate of colorectal cancer screening
will plummet further," according to Edward L.
Cattau, Jr., M.D., FACG, Chair of the College's
National Affairs Committee.
In formulating the payment structure for the new
ASC rule, CMS has
unfairly adopted a too narrow view of the
overall health care environment for ASCs. The
agency has ignored economic realities of the
care provided in ASCs versus the higher cost
setting of the hospital outpatient department.
The new rule's impact on ASCs, many of which
provide GI services only, will be to force these
small businesses to close their doors. A recent
Deutschebank analysis on the proposed rule
concludes that any ASC that provides fewer than
3,500 procedures per year will be put out of
business.
This will dramatically reduce the effectiveness
of Medicare's preventive
colorectal cancer screening, as patient access
is confined to fewer
screening sites, and disenfranchised
beneficiaries wait longer or simply
decide in frustration not to be screened.
About the ASC Rule
The Medicare Modernization Act of 2003 (MMA)
required CMS to modify how ambulatory surgery
centers (ASCs) are reimbursed. In August 2006,
CMS began to implement ASC payment reform and
published a notice of proposed rulemaking (NPRM)
to create significant modifications to the ASC
payment system and sought comments on their
proposal. The final rule will be implemented
beginning with procedures performed on or after
January 1, 2008.
About the ACG
Founded in 1932, the American College of
Gastroenterology (ACG) is an
organization with an international membership of
more than 9,000
individuals from 80 countries.
The College is committed to serving the
clinically oriented digestive disease specialist
through its emphasis on scholarly practice,
teaching and research. The mission of the
College is to serve the evolving needs of
physicians in the delivery of high quality,
scientifically sound, humanistic, ethical, and
cost-effective health care to gastroenterology
patients.